NCI National Clinical Trials Network (NCTN) Program Guidelines

PART 1: Overview of NCTN Program Section IV – Terms/Conditions of Award – Network Group
Integrated Translational Science Centers
information about this policy or the submission process is available on the NIH Public Access
Policy website at: http://publicaccess.nih.gov/.
Information on other federal regulations (and their associated citations/URLs) that may be
applicable to the Network Group Integrated Translational Science Center’s activities is provided
in Part 4: Appendices – Section IV.B.
3.4 Conflict of Interest Policy
The Integrated Translational Science Center awardee(s) receiving NIH funding from a grant or
cooperative agreement must be in compliance with all of the DHSS regulatory requirements for conflict
of interest as outlined by NIH grants policy available at: http://grants.nih.gov/grants/policy/coi. The
policy of the awardee(s) should ensure that there is no reasonable expectation any investigator or staff
member at the Integrated Translational Science Center involved in the design, conduct, or reporting of
research conducted in association with a Network Group Operations Center and its associated Network
Group SDMC will be biased by any conflict of interest (using the definition of investigator provided in
the NIH grants policy). The policy should also be in compliance with the NCI/DCTD/CTEP’s Conflict of
Interest Policy for NCTN Phase 3 Clinical Trials found on the CTEP website at:
http://ctep.cancer.gov/investigatorResources/default.htm#guidelines_policies.
Page 64 of 241